- The legal minimum and what buyers require are different. Plan for the buyer's list.
- HIPAA lets a practice choose Safe Harbor or Expert Determination; buyers have asked for Expert Determination by an independent expert.
- IRB review or consent that covers commercial licensing is the second requirement. Ordinary intake consent rarely covers it.
- Chain of rights means papers for every link: collection, custody, vendor contracts, ownership and who signs.
- Check where you stand with the free health data readiness checker before anyone exports a record.
Do you need IRB approval or patient consent to license de-identified patient data?
Not under HIPAA alone, if the data is properly de-identified. The Privacy Rule says "The requirements of this subpart do not apply to information that has been de-identified in accordance with the applicable requirements of" its de-identification standard (45 CFR 164.502), and OCR adds that "The Privacy Rule does not limit how a covered entity may disclose information that has been de-identified" (HHS OCR). No patient authorization is needed for a de-identified data set.
The Common Rule usually does not reach it either. It "applies to all research involving human subjects conducted, supported, or otherwise subject to regulation by any Federal department or agency" (45 CFR 46.101), and a human subject is someone about whom an investigator "Obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens" (45 CFR 46.102). A private practice licensing de-identified records with no federal research funding is often outside it.
But the legal minimum is not what closes a deal. The buyers have also said what these deals need to get through: de-identification signed off by an independent third party under HIPAA's Expert Determination method, not by the seller; IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights showing who collected the data, who owns it and who can license it. This page is general information, not legal advice.
| Question | Legal minimum, in general | What AI data buyers have asked for |
|---|---|---|
| De-identification | Safe Harbor or Expert Determination; the practice may do either itself | Expert Determination signed off by an independent third party |
| Ethics review or consent | Often none for properly de-identified data | IRB approval, or patient consent that covers commercial licensing |
| Rights | The practice must be permitted to make the disclosure | A documented chain of rights: who collected, who owns, who can license |
Why do buyers ask for more than the law requires?
Because the paperwork is how a deal gets through. A buyer cannot inspect every patient record, so it relies on documents that show someone qualified checked the risk of identification, someone independent reviewed the ethics or patients agreed, and every party in the chain had the right to pass the data on. A practice that has those documents is easier to say yes to; one that does not has to create them first.
Each requirement maps to a rule or a document a practice can produce. The rest of this page takes them in turn and ends with a checklist. To see which of the three you already meet, use the health data readiness checker.
Cardiology and neurology practices hold raw signals as well as notes; the ECG and EEG guide covers what de-identifying a waveform file involves.
Joining a federated network is not a sale, yet it still needs written terms on model weights and outputs; the Apheris trust check lists what to ask.
Who can perform an Expert Determination, and must the expert be independent?
The rule describes the expert as "A person with appropriate knowledge of and experience with generally accepted statistical and scientific principles and methods for rendering information not individually identifiable", who "determines that the risk is very small that the information could be used, alone or in combination with other reasonably available information, by an anticipated recipient to identify an individual who is a subject of the information" and "Documents the methods and results of the analysis that justify such determination" (45 CFR 164.514(b)(1)).
OCR's guidance fills in the rest. "There is no specific professional degree or certification program for designating who is an expert at rendering health information de-identified." Instead "OCR would review the relevant professional experience and academic or other training of the expert". "There is no explicit numerical level of identification risk that is deemed to universally meet the" very small standard, but "the Rule does require that the methods and results of the analysis that justify the determination be documented and made available to OCR upon request" (HHS OCR).
HIPAA does not require the expert to be outside the practice. The buyers have: they asked for sign-off by an independent third party, not by the seller. In practice that means an outside statistician or de-identification specialist with no stake in the deal, given the data dictionary, the free-text fields and the intended recipient.
The recipient matters, because "Experts may design multiple solutions, each of which is tailored to the covered entity's expectations regarding information reasonably available to the anticipated recipient of the data set." A determination need not expire, but "certain de-identification practitioners use the approach of time-limited certifications" (HHS OCR). Keep any re-identification key at home: disclosing "a code or other means of record identification designed to enable coded or otherwise de-identified information to be re-identified constitutes disclosure of protected health information" (45 CFR 164.502). For both methods in detail, see HIPAA de-identification.
If a third party tokenizes or links your records, its agreements are part of the chain too. Our Datavant trust check names them: the data use agreement, the expert determination and the BAA.
When does the Common Rule apply, and what are broad consent and commercial IRBs?
Research under the Common Rule is "a systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge" (45 CFR 46.102). Medical records count as private information, which includes "information that has been provided for specific purposes by an individual and that the individual can reasonably expect will not be made public". Where covered research uses identifiable information, an investigator "shall obtain the legally effective informed consent of the subject", unless an exemption or waiver applies (45 CFR 46.116).
Two exemptions matter for records. One covers secondary research where "the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects". Another covers research that involves only "the investigator's use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164" (45 CFR 46.104).
Broad consent is the Common Rule's way to ask once for future use. It applies "only with respect to the storage, maintenance, and secondary research uses of identifiable private information and identifiable biospecimens", and must give "A general description of the types of research that may be conducted" and "the types of institutions or researchers that might conduct research", for a period that "could be indefinite". If a patient was asked "and refused to consent, an IRB cannot waive consent for the storage, maintenance, or secondary research use" (45 CFR 46.116). Broad consent written for academic research does not automatically cover commercial licensing; read the words.
A practice without its own IRB can use one it does not run. The rule allows for research at an institution where "IRB oversight is conducted by an IRB that is not operated by the institution", as long as the institution and the IRB "shall document the institution's reliance on the IRB for oversight of the research" (45 CFR 46.103). Independent IRBs that review for a fee are often called commercial IRBs. Any IRB "shall have at least five members" and "at least one member who is not otherwise affiliated with the institution" (45 CFR 46.107). Under HIPAA, an IRB or privacy board can also approve a waiver of authorization for research (45 CFR 164.512), and HHS says "Where both the Privacy Rule and the Common Rule apply, both regulations must be followed" (HHS).
Consent questions are sharper for trial participants and DNA donors. Clinical trial data and genomic data each have a guide that quotes the consent and policy text that applies.
How do you document chain of rights for health data?
Build a file that answers one question for every link: who had the data, and what let them pass it on. The table is a starting point.
| Link in the chain | Question | Document that answers it |
|---|---|---|
| Collection | Who collected the data, when, and under which notice and consent? | Intake and consent form versions with their dates of use |
| Custody | Who holds it now: the practice, an EHR vendor, a billing company, a scribe vendor? | Business associate agreements and system list |
| Vendor rights | Does any vendor contract reserve data rights or let the vendor de-identify? | EHR, scribe and billing contracts |
| Ownership | Did the data come with an acquired practice or a departing physician? | Purchase agreements, employment and custodian agreements |
| Prior commitments | Is the data already promised elsewhere? | Research agreements, data use agreements, any exclusivity |
| Authority to license | Who can sign for the practice? | Owner or board approval |
Vendor contracts are where chains break. ONC warns that "Many standard form EHR contracts grant vendors very broad rights to use and commercialize data captured in or created by an EHR", and that "your vendor may claim the right to de-identify and sell your patients' PHI to third parties" (ONC). A business associate "may use or disclose protected health information only as permitted or required by its business associate contract" (45 CFR 164.502), and HHS's sample provisions say the contract "should specify whether the business associate is authorized to use protected health information to de-identify the information" (HHS). If a vendor holds the only copy, the practice needs the vendor's cooperation under that contract. For ownership questions, see who owns patient records.
Health data licensing checklist: the three requirements
Use this as a working list. The health data readiness checker asks the same questions and shows what is missing.
| Requirement | What to have in hand | Rule or source |
|---|---|---|
| Independent Expert Determination | A signed report from an outside expert naming the data set, the anticipated recipient, the methods and the result | 45 CFR 164.514(b)(1); OCR guidance |
| De-identification scope | Free text, images, audio and dates covered, not only the structured fields | 45 CFR 164.514(b) |
| IRB approval or exemption | An IRB approval or exemption determination for the data project, with any reliance agreement | 45 CFR 46.103, 46.104, 46.116 |
| Or patient consent | Consent or authorization language that covers commercial licensing, with the version each patient signed | 45 CFR 46.116; 45 CFR 164.508 |
| Chain of rights | Consent versions, BAAs, vendor contracts, purchase agreements and data use agreements, in one file | 45 CFR 164.502 and 164.504; contracts |
| Signing authority | Written approval from the owner or board | The practice's own governance |
Example: a five-site clinic group checks its records (illustration)
This is an illustration written for this page, not a real organization. A fictional five-site primary care group with 15 years of EHR history sorts its records against the three requirements before any outside conversation.
| Record set | Expert Determination | IRB or consent | Chain of rights | Decision |
|---|---|---|---|---|
| Structured EHR data, 2014 onward | Outside expert engaged | Commercial IRB asked for an exemption determination | Clean: practice-owned, no vendor claim | First candidate |
| Free-text visit notes | Expert requires text de-identification and a sample review | Same IRB review | Clean | Second phase |
| Records from a practice acquired in 2019 | Not started | Not started | Purchase agreement silent on data use | Hold until counsel reviews |
| Ambient scribe transcripts | Not started | Recording consent only | Vendor holds the files; BAA bars other uses | Out |
| Behavioral health program records | Not started | Not started | Separate federal confidentiality rules may apply | Out for now |
Fictional example written for this page. The structured data moves first because all three requirements can be met for it; the rest waits for paperwork, not for a buyer.
Common mistakes when preparing health data for licensing
Most delays come from discovering a missing document after a buyer asks for it.
- Having staff de-identify the data and calling it done, when buyers have asked for an independent expert.
- Removing names from structured fields and leaving identifiers in free-text notes, images or audio.
- Assuming a research consent form covers commercial licensing without reading it.
- Sending the re-identification key, or a code derived from patient details, with the data.
- Forgetting that an EHR or scribe vendor contract may reserve data rights or bar extracts.
- Including records from an acquired practice without checking the purchase agreement.
- Exporting a full data set before anyone has seen a sample. See what a data licensing agreement should include.
What have AI data buyers asked Origin for in health data?
AI data buyers have asked Origin for longitudinal EHR records (patient records over time with diagnoses, medications, labs and outcomes), imaging with reports (CT, MRI, X-ray and pathology slides), behavioral health and specialty care records, and doctor-patient conversation audio with transcripts, which is the newest request.
The buyers have also said what these deals need to get through: de-identification signed off by an independent third party under HIPAA's Expert Determination method, not by the seller; IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights showing who collected the data, who owns it and who can license it. What must come out first: names and every other identifier, in structured fields, free text, images and audio; psychotherapy notes; records of patients who refused or revoked; and any data a vendor contract, purchase agreement or prior commitment does not let the practice license. Records under separate federal confidentiality rules need their own review; see licensing behavioral health records.
Origin is an independent data partner. It does not perform Expert Determination or IRB review. It helps a practice work out what records it holds, which of these three requirements it already meets and what is missing. The practice decides what is shared and signs any license itself, and a buyer may pay Origin when a deal closes.
Does your company hold records like these? See what your data is worth.
Common questions
Do I need IRB approval or patient consent to license de-identified patient data to an AI company?
Not under HIPAA alone, if the data is properly de-identified: de-identified data is outside the Privacy Rule, and the Common Rule mainly covers federally supported research on identifiable information. But AI data buyers have asked for more: an independent Expert Determination, IRB approval or patient consent that covers commercial licensing, and a documented chain of rights. Plan for those three.
How do I document chain of rights for health data I want to license to an AI company?
Build one file that shows every link: who collected the data and under which consent forms, who holds it now under which business associate agreements, what EHR and other vendor contracts say about data rights, whether any records came with an acquired practice, any earlier data use agreements, and who can sign for the practice. Missing links are what stall deals.
Can a practice do its own Expert Determination?
HIPAA allows it: the rule asks for a person with the right statistical and scientific knowledge and experience, not an outside one. AI data buyers have asked for more, a determination signed off by an independent third party rather than by the seller. An outside expert with no stake in the deal meets both the rule and the buyer's requirement.
What is a commercial IRB?
It is an independent institutional review board that reviews research for organizations that do not run their own, usually for a fee. The Common Rule allows an institution to rely on an IRB it does not operate, as long as the reliance is documented. Every IRB needs at least five members, including one not affiliated with the institution.
What is broad consent under the Common Rule?
Broad consent is a one-time permission for storing identifiable private information and using it in future secondary research. Under 45 CFR 46.116(d) it must describe the types of research, the information that might be used, the types of institutions or researchers that might use it, and how long it may be kept. If a patient refuses, an IRB cannot waive that refusal.
Does a HIPAA Expert Determination expire?
The Privacy Rule does not require an expiration date. OCR notes that some experts issue time-limited certifications because data sources and computing power change, and that later releases to the same recipient may need a fresh look. Buyers may ask how old a determination is, so record its date and the recipient it was made for.
Is Safe Harbor de-identification enough for an AI data license?
It meets HIPAA, but it may not meet the buyer. Safe Harbor removes 18 listed identifiers and requires no actual knowledge that the rest could identify someone. The AI data buyers who spoke with Origin asked for Expert Determination by an independent third party instead, which an expert can tailor to the data set and to the recipient.
Sources and further reading
- 45 CFR 164.502: uses and disclosures of protected health information, general rules (eCFR)
- 45 CFR 164.514: de-identification of protected health information (eCFR)
- HHS Office for Civil Rights: Guidance Regarding Methods for De-identification of Protected Health Information
- 45 CFR 46.101: to what the Common Rule applies (eCFR)
- 45 CFR 46.102: definitions for the Common Rule (eCFR)
- 45 CFR 46.103: assuring compliance, reliance on an outside IRB (eCFR)
- 45 CFR 46.104: exempt research (eCFR)
- 45 CFR 46.107: IRB membership (eCFR)
- 45 CFR 46.116: informed consent and broad consent (eCFR)
- 45 CFR 164.512: uses and disclosures for research purposes (eCFR)
- HHS: HIPAA frequently asked questions, Authorizations
- HHS: Business Associate Contracts, sample business associate agreement provisions
- ONC (HealthIT.gov): EHR Contracts Untangled (PDF)
